(Q34255299)

31 July 2017

1 reference

title

Current perspectives on common variable immunodeficiency (CVID). (English)

1 reference

common variable immunodeficiency

31 July 2017

main subject

1 reference

G P Spickett

1

1 reference

31 July 2017

publication date

1 April 2001

1 reference

Clinical & Experimental Allergy

31 July 2017

published in

1 reference

31 July 2017

volume

31

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

536-542

1 reference

Common variable immunodeficiency: clinical and immunological features of 248 patients.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

An essential role for BLNK in human B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Common variable immunodeficiency: how many diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

B Cell Lines from a Subset of Patients with Common Variable Immunodeficiency Undergo Enhanced Apoptosis Associated with an Increased Display of CD95 (Apo-1/fas), Diminished CD38 Expression, and Decreased IgG and IgA Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Prospective study of cancer in patients with hypogammaglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Mutations in the mu heavy-chain gene in patients with agammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Mannose Binding Lectin Polymorphisms are Associated With Early Age of Disease Onset and Autoimmunity in Common Variable Immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Granulomatous disease in common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Extensive deletion of immunoglobulin heavy chain constant region genes in the absence of recurrent infections: when is IgG subclass deficiency clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Serum neopterin patients with X-linked and acquired 'common variable' hypogammaglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Development of a common variable immunodeficiency in IgA-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Splenic lesions in hypogammaglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Retinal vasculitis occurring with common variable immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

Bilateral consecutive central corneal perforations associated with hypogammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01117.X

10.1046/J.1365-2222.2001.01117.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference